Zenotech Laboratories Limited (ZENOTECH.BO)
INR 59.96
(-3.17%)
INR 59.96
(-3.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 156.64 Million INR | -15.79% |
| 2022 | 186.02 Million INR | -20.65% |
| 2021 | 234.43 Million INR | -37.38% |
| 2020 | 374.35 Million INR | 4.21% |
| 2019 | 359.25 Million INR | -21.36% |
| 2018 | 456.85 Million INR | 15.01% |
| 2017 | 397.23 Million INR | -65.95% |
| 2016 | 1.16 Billion INR | 17.85% |
| 2015 | 989.82 Million INR | 9.17% |
| 2014 | 906.71 Million INR | 35.45% |
| 2013 | 669.41 Million INR | 63.71% |
| 2012 | 408.91 Million INR | 143.26% |
| 2011 | 168.09 Million INR | 55.62% |
| 2010 | 108.01 Million INR | -22.99% |
| 2009 | 140.26 Million INR | 6317028.75% |
| 2008 | 2220.36 INR | -16.82% |
| 2007 | 2669.35 INR | -41.32% |
| 2006 | 4549.06 INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 147.57 Million INR | 116.3% |
| 2024 Q1 | -905.41 Million INR | -677.99% |
| 2023 Q2 | 171.81 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 156.64 Million INR | -15.79% |
| 2023 Q4 | 156.64 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 171.81 Million INR | 0.0% |
| 2022 FY | 186.02 Million INR | -20.65% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 186.02 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 234.43 Million INR | -37.38% |
| 2021 Q4 | 234.43 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 293.55 Million INR | 0.0% |
| 2020 FY | 374.35 Million INR | 4.21% |
| 2020 Q2 | 387.26 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 374.35 Million INR | 0.0% |
| 2019 Q4 | 359.25 Million INR | 0.0% |
| 2019 Q2 | 558.01 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 359.25 Million INR | -21.36% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 456.85 Million INR | 15.01% |
| 2018 Q4 | 456.85 Million INR | 0.0% |
| 2018 Q2 | 353.06 Million INR | 0.0% |
| 2017 Q4 | 397.23 Million INR | 0.0% |
| 2017 Q2 | 515.45 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 397.23 Million INR | -65.95% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 1.16 Billion INR | 17.85% |
| 2016 Q4 | 1.16 Billion INR | 3.81% |
| 2016 Q3 | 1.12 Billion INR | 3.85% |
| 2016 Q2 | 1.08 Billion INR | 0.0% |
| 2015 Q4 | 989.82 Million INR | 0.0% |
| 2015 FY | 989.82 Million INR | 9.17% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 952.2 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2014 FY | 906.71 Million INR | 35.45% |
| 2014 Q2 | 692.83 Million INR | 0.0% |
| 2014 Q4 | 906.71 Million INR | 0.0% |
| 2013 Q2 | 552.54 Million INR | 0.0% |
| 2013 FY | 669.41 Million INR | 63.71% |
| 2013 Q4 | 669.41 Million INR | 0.0% |
| 2012 Q4 | 408.91 Million INR | 0.0% |
| 2012 FY | 408.91 Million INR | 143.26% |
| 2012 Q2 | 515.31 Million INR | 0.0% |
| 2011 FY | 168.09 Million INR | 55.62% |
| 2010 FY | 108.01 Million INR | -22.99% |
| 2009 FY | 140.26 Million INR | 6317028.75% |
| 2008 FY | 2220.36 INR | -16.82% |
| 2007 FY | 2669.35 INR | -41.32% |
| 2006 FY | 4549.06 INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 117.72 Million INR | -33.063% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 20.634% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -1665.645% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.903% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 90.572% |
| Add-Shop E-Retail Limited | 159.2 Million INR | 1.605% |
| Bacil Pharma Limited | 1.12 Million INR | -13774.934% |
| BDH Industries Limited | 312.53 Million INR | 49.878% |
| Beryl Drugs Limited | 85.63 Million INR | -82.923% |
| Cian Healthcare Limited | 1.03 Billion INR | 84.855% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -7261.278% |
| Concord Drugs Limited | 249.88 Million INR | 37.312% |
| Deccan Health Care Limited | 111.33 Million INR | -40.698% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 3.109% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -509.5% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 22.295% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 84.278% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 90.873% |
| Makers Laboratories Limited | 569.18 Million INR | 72.478% |
| Medi-Caps Limited | 63.01 Million INR | -148.584% |
| Panchsheel Organics Limited | 340.2 Million INR | 53.954% |
| Parmax Pharma Limited | 117.56 Million INR | -33.241% |
| Parnax Lab Limited | 1.17 Billion INR | 86.619% |
| Patidar Buildcon Limited | 25.57 Million INR | -512.576% |
| Phaarmasia Limited | 211.49 Million INR | 25.933% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 46.257% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -1.021% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -52290.635% |
| Smruthi Organics Limited | 485.72 Million INR | 67.749% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -273.22% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 90.862% |
| Trident Lifeline Limited | 331.26 Million INR | 52.712% |
| Transchem Limited | 6.72 Million INR | -2231.071% |
| Trinity League India Limited | 876 Thousand INR | -17782.192% |
| Tyche Industries Limited | 101.64 Million INR | -54.119% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 10.572% |
| Vivanza Biosciences Limited | 148.63 Million INR | -5.394% |
| PRAVEG LIMITED | 767.53 Million INR | 79.591% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 89.561% |
| Sunil Healthcare Limited | 902.83 Million INR | 82.649% |
| Syschem (India) Limited | 1.07 Billion INR | 85.37% |
| Zenith Healthcare Limited | 24.03 Million INR | -551.75% |
| Zenlabs Ethica Limited | 301.35 Million INR | 48.019% |
| Mercury Laboratories Limited | 171.18 Million INR | 8.494% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -646.298% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -191.998% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 84.403% |
| Roopa Industries Limited | 493.08 Million INR | 68.231% |
| PANJON LTD. | 25.38 Million INR | -517.137% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 24.848% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -945.784% |
| Anuh Pharma Limited | 1.54 Billion INR | 89.858% |
| Crestchem Limited | 23.94 Million INR | -554.145% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1068.579% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -32.502% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 91.584% |
| Trimurthi Limited | 101.36 Thousand INR | -154446.172% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 22.442% |
| Norris Medicines Limited | 278.17 Million INR | 43.687% |
| Veerhealth Care Limited | 62.78 Million INR | -149.519% |
| Lactose (India) Limited | 536.39 Million INR | 70.796% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 81.198% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 86.148% |
| Gennex Laboratories Limited | 535.21 Million INR | 70.732% |
| Denis Chem Lab Limited | 289.82 Million INR | 45.95% |
| Colinz Laboratories Limited | 24.1 Million INR | -549.857% |
| Godavari Drugs Limited | 957.86 Million INR | 83.646% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 67.924% |
| Bharat Parenterals Limited | 2.65 Billion INR | 94.103% |
| Coral Laboratories Limited | 281.83 Million INR | 44.419% |
| Evoq Remedies Limited | 116.23 Million INR | -34.772% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 85.189% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 92.333% |
| Natural Capsules Limited | 1.47 Billion INR | 89.396% |
| Auro Laboratories Limited | 433.09 Million INR | 63.831% |